Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in nAMD

This randomized clinical trial evaluates extended dosing with faricimab in patients with neovascular age-related macular degeneration (nAMD).
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research